# Opioids Dosage Conversion vs MGI Associates, PC

The clearest difference is rating: MGI Associates, PC at 5.0 against Opioids Dosage Conversion's 4.3. MGI Associates, PC also leads on review sentiment (100% vs 78%) and update cadence (every 2 months vs every 4 months). Opioids Dosage Conversion's advantage is ratings volume (19 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

MGI Associates, PC holds the better App Store score, 5.0 against 4.3. That said, the two scores are not equally well evidenced: Opioids Dosage Conversion has 19 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 78% of Opioids Dosage Conversion's written reviews are positive against 100% of MGI Associates, PC's.

Opioids Dosage Conversion ships an update every 4 months, MGI Associates, PC every 2 months. The most recent releases landed on October 21, 2026 and October 24, 2026 respectively.

## The numbers

| Metric | Opioids Dosage Conversion | MGI Associates, PC |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.3 (19 ratings)](https://appshunter.io/ios/app/opioids-dosage-conversion/id382383903/reviews) | **[5.0 (1 ratings)](https://appshunter.io/ios/app/mgi-associates-pc/id1027789475/reviews)** |
| Number of ratings | **19** | 1 |
| Positive reviews | 77.8% of reviews | **100.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 4 months | **Every 2 months** |
| Monetization | Free | Free |
| Size | 2 MB | 29 MB |
| Requires iOS | 15.6 | **14.2** |
| Devices | **iPhone, iPad, iPod** | iPhone, iPod |
| Age rating | 17+ | 4+ |
| Developer | [Chris Marcellino MD LLC](https://appshunter.io/developer/1161719220) | [Volano Software Company](https://appshunter.io/developer/544452420) |

## What reviewers say

### Opioids Dosage Conversion

[App page](https://appshunter.io/ios/app/opioids-dosage-conversion/id382383903)

This app is a calculator for trained medical professionals to convert opioid analgesic dosages. It supports various common opioids and administration routes, offering features like breakthrough dosing and cross-tolerance calculations.

**Highlights:** Opioid dosage conversion, Multiple drug support, Multiple route support, Breakthrough dosing calculator, Incomplete cross tolerance option, Instructional details

**Features:** macOS Compatibility

**In-app purchases:** none


### MGI Associates, PC

[App page](https://appshunter.io/ios/app/mgi-associates-pc/id1027789475)

This medical app provides information on gastrointestinal disorders and diseases. It offers insights into digestive tract health and wellness, with services including consultations and endoscopic procedures.

**Highlights:** Gastrointestinal disorder information, Digestive tract health promotion, Consultative services, Endoscopic services

**Features:** macOS Compatibility

**In-app purchases:** none


## Frequently asked questions

### Is Opioids Dosage Conversion free?

Opioids Dosage Conversion is free to download, with no in-app purchases.

### Is MGI Associates, PC free?

MGI Associates, PC is free to download, with no in-app purchases.

### Which has better reviews, Opioids Dosage Conversion or MGI Associates, PC?

MGI Associates, PC is rated higher. Opioids Dosage Conversion averages 4.3 out of 5 from 19 ratings, while MGI Associates, PC averages 5.0 from 1 ratings.

### Do Opioids Dosage Conversion or MGI Associates, PC have ads?

Neither Opioids Dosage Conversion nor MGI Associates, PC shows ads.

### Which is updated more often, Opioids Dosage Conversion or MGI Associates, PC?

Opioids Dosage Conversion ships an update every 4 months, and MGI Associates, PC every 2 months. Most recently, Opioids Dosage Conversion was updated on October 21, 2026 and MGI Associates, PC on October 24, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*